Abstract
Dapagliflozin is a novel sodium-glucose cotransporter type 2 inhibitor. This work aims to develop a new validated sensitive RP-HPLC coupled with a mas......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
